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ABSTRACT 
 
    The prevalence and anthelmintic efficacy of Abamectin against gastrointestinal parasites under field 
conditions in Faisalabad (Punjab, Pakistan) was studied in 100 horses. The overall prevalence of 
gastrointestinal parasites was 75%, including Strongylus spp.  (50%),  Oxyuris equi (12%),  Parascaris 
equorum (8%) and mixed infection (5%). Among these naturally infected animals, 15 were selected. These 
horses were assigned to three groups on the basis of prevalent species of gastrointestinal parasites. Each 
group had five animals, comprising four treatment horses and a control horse. Abamectin was evaluated 
against these gastrointestinal parasites with a single shot at the dose rate of 0.2 mg/kg body weight 
administered through subcutaneous route which resulted in 98% reduction in faecal egg count after day 14 
post-treatment. Non-treated horses remained positive for gastrointestinal parasites. No adverse reactions 
were observed during the experimental period. It was concluded that Abamectin is highly effective against 
gastrointestinal parasites in horses. 
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INTRODUCTION 
 
Parasitic diseases are the major obstacle in the 
growth and development of animal health. Incidence of 
clinical and sub-clinical diseases of horses can be 
minimized through controlling the gastrointestinal 
parasites (Sattar, 2003). There are various approaches to 
achieve this goal, but traditionally, control has relied on 
regular treatment with anthelmintic drugs (Meara and 
Mulcahy, 2002).  
Abamectin is derived from Streptomyces 
avermitilis and has potent antiparasitic activity 
(Echeverria  et al., 2001). This compound has shown 
excellent antiparasitic activity against a wide range of 
gastrointestinal parasites of equines (Bennett, 1986). A 
variety of adverse reactions have been reported in 
horses after parentral administration of Abamectin at 
the recommended dose of 0.2 mg/kg body weight 
(Leaning, 1983; Reed, 1983). These reactions have 
occurred in a small percentage of treated horses and the 
drug is now sold as a paste for oral administration. 
  Abamectin at a dose rate of 0.2 mg/kg body 
weight is currently used by many horse owners, who 
are claiming excellent results without any adverse 
sideeffects. The aim of the present study was to 
determine the prevalence of gastrointestinal parasites in 
horses in and around Faisalabad and to study the 
anthelmintic efficacy of Abamectin
  injected 
subcutaneously against gastrointestinal parasites.  
 
MATERIALS AND METHODS 
Animals 
One hundred horses were studied for the 
prevalence of gastrointestinal parasites from different 
localities in and around Faisalabad (Punjab, Pakistan). 
Intestinal contents were taken for counting and 
identifying species of gastrointestinal parasites. 
Infections were confirmed before the beginning of the 
treatment by direct smear and flotation technique. After 
treatment, experimental animals were penned by 
treatment groups until the end of the observational 
period. 
 
Design of study 
Fifteen horses positive for gastrointestinal parasites 
were randomly assigned to three groups based on the 
species of the prevalent gastrointestinal parasites i.e. 
Strongylus spp. (group-I), Oxyuris equi (group-II) and 
Parascaris equorum (group-III). Each group had five 
horses, with four treatment and one control. Treatment 
groups of horses were administered a single shot of 
Abamectin (Abamec
®; Selmore Agencies Pvt.) at the 
dose rate of 0.2 mg/kg body weight through 
subcutaneous route, while horses of control groups 
were kept untreated. Treated horses were observed for 
possible adverse reactions for 2 hours after injection. 
General body conditions of all treated animals were 
observed throughout the study period regarding to 
clinical signs i.e. soundness, irritation, depression, feed 
intake and faecal appearance. Faecal egg counts were 
performed for all animals on days 0, 3, 7 and 14 post-
treatment. 
 
Detection of parasites in faeces 
Faecal samples of all horses were collected and 
analyzed by using McMaster technique (Soulsby, 
1982). After that, parasites were identified on the basis Pakistan Vet. J., 2008, 28(2): 76-78. 
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of classifications described by Noda (1979), Georgi and 
Georgi (1990) and Lichtenfels et al. (1998). 
 
Data analysis 
Anthelmintic efficacy was calculated by the faecal 
egg count reduction (FECR) test (Coles et al., 1992) 
according to the following formula: 
 
FECR (%)  =  Pre-treatment EPG - Post-treatment EPG × 100 
Pretreatment EPG 
 
RESULTS AND DISCUSSION 
 
Prevalence of GIT parasites 
Out of 100 horses, 75 animals were positive for the 
gastrointestinal parasitic infection, indicating that the 
prevalence was 75%. Species wise prevalence was 50, 
12, 8 and 5% for Strongylus spp.,  Oxyuris equi, 
Parascaris equorum and mixed infection, respectively. 
These results are in accordance with Hutchison and 
Mfitlidoze (1989), who reported that 80% horses in the 
Australian subcontinent were infected with gastro- 
intestinal parasitism.  
 
Faecal egg count reductions 
All horses of the treatment groups were positive for 
GIT parasites with the mean eggs per gram (EPG) value 
on day zero was 1553.75. This decreased to 450, 112.5 
and 20.25 on 3, 7 and 14 days post-treatment, 
respectively (Table 1). The efficacy of Abamectin at the 
dose rate of 0.2 mg/kg body weight was 71.04, 92.75 
and 98.69% on the day 3, 7 and 14 of treatment. 
However, all horses of the control groups were found 
positive for gastrointestinal parasitism, with mean EPG 
value of 1522.5 at the start of trial that increased to 
1586.25, 1687.5 and 1792.5 at day 3, 7 and 14 post-trial 
(Table 2). In this study, more than 98% reduction in 
faecal egg count was observed after 14 days of 
administering Abamectin subcutaneously. Trobert et al. 
(1982) reported that after treatment of six horses with 
Ivermectin products at 0.2 mg/kg body weight, neither 
Strongylus  nor  P. equorum eggs were found in the 
faecal samples on post-treatment day 7. Our findings 
did not coincide with these results because of the huge 
gastrointestinal parasitic burden just before the 
treatment.  
Our results agree with the findings of Itagaki et al. 
(1993) and Yoshihara et al. (1994), that a wide range of 
species of parasites were observed, with the exception 
of small Strongylus. The results are also comparable 
with the findings of Adquith and Kivipelto (1987). 
They treated 120 parasitic infected horses and ponies 
with Ivermectin at dose rate of 1ml/50 kg (0.2 mg/kg) 
body weight. The EPG count in treated animals was 
reduced to almost zero on day 14 post-medication. 
Dipietro et al. (1982) and Klei et al. (1993) reported the 
potent anthelmintic efficacy of Ivermectin against these 
parasites at dosage of 200µg/kg b.wt. In this regard, our 
study has confirmed that Abamectin has excellent 
anthelmintic efficacy against many species of GIT 
parasites.  
 
 
 
Table 1: Efficacy of Abamectin against gastrointestinal parasites of horses 
Reduction in EPG after treatment 
Parasite                    Day 0               Day 3                    Day 7                      Day 14 
Strongylus                 1850        460(75.13)           90(95.13)                 15(99.18) 
Oxyuris equi                     925        285(69.19)             65(89.12)              12(98.70) 
Parascaris equorum                    780        290(62.82)             80(89.74)                   19(97.56) 
Strongylus + Oxyuris equi             2660        765(71.24)             215(91.92)                35(98.68) 
Mean                  1553.75          450(71.04)            112.5(92.75)            20.25(98.69) 
 Figures in parentheses indicate reduction (%) in EPG. 
 
 
 
Table 2: Mean eggs per gram (EPG) of faeces in untreated group of horses 
Mean EPG on different days 
Parasite                      Day 0               Day 3                       Day 7                       Day 14 
Strongylus                 1740            1845                    1925                               1990 
Oxyuris equi                 885                 950                    1025                            1180 
Parascaris equorum              790                 830                           945                            1035 
Strongylus + Oxyuris equi         2675                2720                 2855                           2965 
Mean                 1522.5       1586.25(4.02)       1687.5(9.78)           1792.5(15.06) 
Figures in parentheses indicate percent increase in EPG. 
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General clinical conditions 
No abnormalities were observed in physical 
conditions such as soundness, appetite and faecal 
appearance in any of the treated horse during 14 days 
post-treatment period. Davies et al. (2000) reported that 
animals medicated with Ivermectin showed no adverse 
effects, except a minor type of local reaction in the 
form of swelling at the site of injection, which sub-
sided within a short period after the injection. But no 
swelling was observed in our study after injecting 
Abamectin subcutaneously in any of the animal due to 
the use of Abamectin instead of Ivermectin. 
 
Conclusion 
This study showed that a single subcutaneous 
injection of Abamectin
 administered at dose rate of 0.2 
mg/kg body weight was highly effective against 
gastrointestinal parasites in horses. 
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